Barclays started coverage on shares of Phibro Animal Health (NASDAQ:PAHC) in a research report released on Tuesday, BenzingaRatingsTable reports. The brokerage issued an underweight rating and a $25.00 price target on the stock.

Several other equities analysts also recently issued reports on PAHC. Zacks Investment Research raised shares of Phibro Animal Health from a sell rating to a hold rating in a report on Tuesday, February 12th. ValuEngine downgraded shares of Phibro Animal Health from a hold rating to a sell rating in a report on Wednesday, February 13th. BidaskClub downgraded shares of Phibro Animal Health from a sell rating to a strong sell rating in a report on Thursday, February 14th. Gabelli raised shares of Phibro Animal Health from a hold rating to a buy rating and set a $42.00 price target for the company in a report on Wednesday, May 8th. They noted that the move was a valuation call. Finally, Guggenheim initiated coverage on shares of Phibro Animal Health in a report on Thursday, May 23rd. They set a neutral rating for the company. Two research analysts have rated the stock with a sell rating, three have given a hold rating and two have assigned a buy rating to the company. The stock has a consensus rating of Hold and a consensus price target of $41.50.

NASDAQ:PAHC opened at $28.03 on Tuesday. The stock has a market cap of $1.13 billion, a PE ratio of 16.11, a price-to-earnings-growth ratio of 4.45 and a beta of 0.74. Phibro Animal Health has a 52 week low of $27.32 and a 52 week high of $54.62. The company has a quick ratio of 1.98, a current ratio of 3.41 and a debt-to-equity ratio of 1.48.

Phibro Animal Health (NASDAQ:PAHC) last released its quarterly earnings data on Monday, May 6th. The company reported $0.39 EPS for the quarter, missing analysts’ consensus estimates of $0.43 by ($0.04). The business had revenue of $205.70 million for the quarter, compared to the consensus estimate of $214.94 million. Phibro Animal Health had a return on equity of 33.77% and a net margin of 8.12%. Phibro Animal Health’s revenue was down 1.5% on a year-over-year basis. During the same period in the previous year, the business posted $0.46 earnings per share. On average, equities research analysts expect that Phibro Animal Health will post 1.52 EPS for the current year.

The business also recently announced a quarterly dividend, which will be paid on Wednesday, June 26th. Shareholders of record on Wednesday, June 5th will be paid a $0.12 dividend. This represents a $0.48 dividend on an annualized basis and a dividend yield of 1.71%. The ex-dividend date of this dividend is Tuesday, June 4th. Phibro Animal Health’s dividend payout ratio is presently 27.59%.

Several hedge funds and other institutional investors have recently made changes to their positions in the business. Ceredex Value Advisors LLC raised its stake in shares of Phibro Animal Health by 5.8% in the first quarter. Ceredex Value Advisors LLC now owns 886,646 shares of the company’s stock worth $29,260,000 after acquiring an additional 48,694 shares during the last quarter. Foresters Investment Management Company Inc. raised its stake in shares of Phibro Animal Health by 12.0% in the fourth quarter. Foresters Investment Management Company Inc. now owns 601,233 shares of the company’s stock worth $19,336,000 after acquiring an additional 64,650 shares during the last quarter. Dimensional Fund Advisors LP raised its stake in shares of Phibro Animal Health by 2.2% in the first quarter. Dimensional Fund Advisors LP now owns 542,922 shares of the company’s stock worth $17,916,000 after acquiring an additional 11,535 shares during the last quarter. Segall Bryant & Hamill LLC raised its stake in shares of Phibro Animal Health by 13.4% in the fourth quarter. Segall Bryant & Hamill LLC now owns 518,968 shares of the company’s stock worth $16,690,000 after acquiring an additional 61,134 shares during the last quarter. Finally, Goldman Sachs Group Inc. raised its stake in shares of Phibro Animal Health by 10.1% in the first quarter. Goldman Sachs Group Inc. now owns 500,901 shares of the company’s stock worth $16,530,000 after acquiring an additional 45,881 shares during the last quarter. 50.25% of the stock is owned by institutional investors.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as a diversified animal health and mineral nutrition company primarily in the United States. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for a range of food animals, including poultry, swine, beef and dairy cattle, and aquaculture.

Featured Story: The Discount Rate – What You Need to Know

Receive News & Ratings for Phibro Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.